Genomics IPOs Sizzle In Summer; Elitra In Line To Test Investor Appetite
Elitra Pharmaceuticals is in line to test the size of Wall Street's healthy appetite for genomic-related initial public offerings.
Elitra Pharmaceuticals is in line to test the size of Wall Street's healthy appetite for genomic-related initial public offerings.